About: Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.86 (+4.49%)
CDIO NASDAQ Cardio Diagnostics Holdings Inc
Cardio Diagnostics Holdings Inc share price
CDIO price activity
Last Price
$1.860
Change (24hr)
0.08 USD (4.49%)
Volume
698
Volume (4w avg)
-
Open
$1.86
Day Range
$1.86 - $1.86
Previous Close
$1.78
Last Trade
13 Oct, 1:30 pm GMT+0
Delayed
13 Oct, 1:30 pm GMT+0
CDIO price performance
Delayed
13 Oct, 1:30 pm GMT+0
CDIO Market Signals